CG Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	14.62	257.07	8.27	88.14	53.61
Short-Term Investments	646.43	484.93	179.41	55.34	-
Cash & Short-Term Investments	661.05	742	187.67	143.48	53.61
Cash Growth	16.69%	295.37%	30.80%	167.65%	-
Other Receivables	-	0.78	0.09	0.3	0
Receivables	0.56	0.78	0.09	0.3	0
Prepaid Expenses	11.42	11.43	6.36	3.42	4.8
Total Current Assets	673.03	754.21	194.12	147.21	58.41
Property, Plant & Equipment	1.22	0.49	0.49	0.51	0.2
Long-Term Deferred Charges	0.4	-	4.67	-	-
Other Long-Term Assets	0.12	0.09	0.02	0.03	0.09
Total Assets	701.45	754.8	199.3	147.75	58.69
Accounts Payable	7.13	6.52	3.24	0.99	1
Accrued Expenses	22.73	14.23	9.68	5.12	1.89
Current Portion of Long-Term Debt	-	-	-	8.97	2.94
Current Portion of Leases	0.29	0.19	0.22	0.19	0.07
Other Current Liabilities	0.24	0.44	1.12	0.17	0.07
Total Current Liabilities	30.38	21.37	14.25	15.43	5.98
Long-Term Debt	-	-	-	6.53	12.06
Long-Term Leases	0.71	0.05	0.24	0.26	0.05
Other Long-Term Liabilities	-	-	0.01	0.35	0.35
Total Liabilities	31.09	21.42	14.51	22.57	18.44
Common Stock	0.01	0.01	-	-	0
Additional Paid-In Capital	964.21	951.35	6.84	3.64	3.27
Retained Earnings	-293.86	-217.98	-129.94	-81.34	-45.89
Total Common Equity	670.36	733.38	-123.1	-77.69	-42.62
Shareholders' Equity	670.36	733.38	184.79	125.18	40.25
Total Liabilities & Equity	701.45	754.8	199.3	147.75	58.69
Total Debt	0.99	0.24	0.46	15.94	15.13
Net Cash (Debt)	660.06	741.76	187.21	127.54	38.48
Net Cash Growth	16.60%	296.21%	46.79%	231.45%	-
Net Cash Per Share	9.15	11.87	43.23	34.09	10.54
Filing Date Shares Outstanding	76.25	76.22	66.64	3.84	3.65
Total Common Shares Outstanding	76.23	76.15	5.22	3.84	3.65
Working Capital	642.65	732.84	179.87	131.78	52.43
Book Value Per Share	8.79	9.63	-23.57	-20.22	-11.67
Tangible Book Value	670.36	733.38	-123.1	-77.69	-42.62
Tangible Book Value Per Share	8.79	9.63	-23.57	-20.22	-11.67

Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q